BioInvent International Future Growth
Future criteria checks 5/6
BioInvent International is forecast to grow earnings and revenue by 102.7% and 77.3% per annum respectively while EPS is expected to grow by 166.6% per annum.
Key information
102.7%
Earnings growth rate
166.6%
EPS growth rate
| Biotechs earnings growth | 34.9% |
| Revenue growth rate | 77.3% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 27 Sep 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 606 | 261 | N/A | 263 | 1 |
| 12/31/2025 | 647 | 446 | N/A | 155 | 1 |
| 12/31/2024 | 64 | -354 | N/A | -419 | 1 |
| 6/30/2024 | 53 | -383 | -376 | -364 | N/A |
| 3/31/2024 | 61 | -335 | -341 | -329 | N/A |
| 12/31/2023 | 71 | -330 | -355 | -342 | N/A |
| 9/30/2023 | 77 | -311 | -358 | -341 | N/A |
| 6/30/2023 | 68 | -304 | -77 | -62 | N/A |
| 3/31/2023 | 326 | -48 | -53 | -40 | N/A |
| 12/31/2022 | 326 | -43 | -54 | -41 | N/A |
| 9/30/2022 | 310 | -43 | -54 | -45 | N/A |
| 6/30/2022 | 295 | -42 | -289 | -276 | N/A |
| 3/31/2022 | 30 | -266 | -290 | -276 | N/A |
| 12/31/2021 | 19 | -278 | -259 | -246 | N/A |
| 9/30/2021 | 113 | -171 | -153 | -141 | N/A |
| 6/30/2021 | 126 | -141 | -123 | -115 | N/A |
| 3/31/2021 | 137 | -123 | -85 | -78 | N/A |
| 12/31/2020 | 147 | -76 | -69 | -63 | N/A |
| 9/30/2020 | 74 | -146 | -125 | -119 | N/A |
| 6/30/2020 | 76 | -150 | -117 | -112 | N/A |
| 3/31/2020 | 93 | -144 | -124 | -120 | N/A |
| 12/31/2019 | 94 | -139 | -129 | -125 | N/A |
| 9/30/2019 | 79 | -130 | -139 | -136 | N/A |
| 6/30/2019 | 68 | -116 | -152 | -148 | N/A |
| 3/31/2019 | 45 | -126 | -156 | -152 | N/A |
| 12/31/2018 | 39 | -123 | -145 | -141 | N/A |
| 9/30/2018 | 42 | -124 | -136 | -126 | N/A |
| 6/30/2018 | 42 | -123 | -128 | -116 | N/A |
| 3/31/2018 | 43 | -103 | N/A | -99 | N/A |
| 12/31/2017 | 45 | -101 | N/A | -76 | N/A |
| 9/30/2017 | 62 | -75 | N/A | -76 | N/A |
| 6/30/2017 | 56 | -82 | N/A | -75 | N/A |
| 3/31/2017 | 55 | -85 | N/A | -81 | N/A |
| 12/31/2016 | 71 | -63 | N/A | -72 | N/A |
| 9/30/2016 | 50 | -76 | N/A | -59 | N/A |
| 6/30/2016 | 51 | -70 | N/A | -46 | N/A |
| 3/31/2016 | 45 | -69 | N/A | -50 | N/A |
| 12/31/2015 | 16 | -91 | N/A | -73 | N/A |
| 9/30/2015 | 8 | -98 | N/A | -87 | N/A |
| 6/30/2015 | 17 | -86 | N/A | -79 | N/A |
| 3/31/2015 | 46 | -57 | N/A | -73 | N/A |
| 12/31/2014 | 47 | -54 | N/A | -76 | N/A |
| 9/30/2014 | 95 | -5 | N/A | -27 | N/A |
| 6/30/2014 | 92 | -10 | N/A | -42 | N/A |
| 3/31/2014 | 72 | -23 | N/A | -55 | N/A |
| 12/31/2013 | 82 | -18 | N/A | -55 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0H22 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).
Earnings vs Market: 0H22 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 0H22 is expected to become profitable in the next 3 years.
Revenue vs Market: 0H22's revenue (77.3% per year) is forecast to grow faster than the UK market (3.6% per year).
High Growth Revenue: 0H22's revenue (77.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0H22's Return on Equity is forecast to be high in 3 years time